Literature DB >> 9250904

Progressive systemic sclerosis associated with primary small cell carcinoma of the stomach.

S Shikuwa1, M Senju, H Tanaka, M Kusano, G Matsuda, K Omagari, Y Mizuta, F Takeshima, K Makiyama, M Ito, I Sekine, S Kohno.   

Abstract

A 64-year-old man with a 5-year history of progressive systemic sclerosis (PSS) was hospitalized because of melena. Radiological and endoscopic examinations showed an ulcerative lesion with sharply demarcated and raised margins in the fornix of the stomach. Tumor markers--serum carcinoembryonic antigen (CEA, 11.3 mg/ml) and neuron-specific enolase (NSE, 38.9 ng/ml) were elevated. Histological examination of endoscopic biopsy specimens (and of necropsy specimens) showed proliferation of atypical small round cells. Immunohistological examination of these cells showed they were positive for epithelial membranous antigen (EMA), and neuron-specific enolase (NSE), but negative for UCHL1, leukocyte common antigen (LCA), anti-leukocyte B-cell (MB1), and anti-leukocyte T-cell (MT1) antigens. Based on these histological and immunohistological tests, a definite diagnosis of small cell carcinoma of the stomach with PSS was established. Our case is a rare combination of PSS and gastric small cell carcinoma. We also reviewed the literature for the association between PSS and gastric cancer in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250904     DOI: 10.1007/bf02934096

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  4 in total

1.  Scleroderma and malignancy: an epidemiological study.

Authors:  A K Rosenthal; J K McLaughlin; M S Linet; I Persson
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

2.  Cancer associated with collagen-vascular disease.

Authors:  J H Talbott; C Hoch-Ligeti
Journal:  South Med J       Date:  1979-02       Impact factor: 0.954

Review 3.  Rheumatologic manifestations of cancer.

Authors:  D S Caldwell; R M McCallum
Journal:  Med Clin North Am       Date:  1986-03       Impact factor: 5.456

4.  Cancer and scleroderma.

Authors:  S C Duncan; R K Winkelmann
Journal:  Arch Dermatol       Date:  1979-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.